Published 2023 | Version v1
Publication

The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis

Additional details

Identifiers

URL
https://hdl.handle.net/11567/1165357
URN
urn:oai:iris.unige.it:11567/1165357

Origin repository

Origin repository
UNIGE